Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Hlavní autor: | Tania, Umme |
---|---|
Další autoři: | Khan, Tanisha |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2023
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/18736 |
Podobné jednotky
-
A review on targeted therapies for lung cancer
Autor: Ashraf, Anushey
Vydáno: (2023) -
Molecules associated with the development of lung cancer
Autor: Rahman, Adree, a další
Vydáno: (2023) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Autor: Paul, Pulock
Vydáno: (2024) -
Protein biomarkers for Lung Cancer: a bioinformatic approach
Autor: Jeba, Joynob
Vydáno: (2017) -
Potential of liposomes for the treatment of lung cancer- a review
Autor: Mim, Shanzida
Vydáno: (2023)